ReviewFrontiers in oncology2019

Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma.

Dana L Casey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.